Biochemical analysis in this study showed increased potency of cancer-related variants of NSD2 (E1099K or T1150A) and NSD3 (E1181K or T1232A) in dimethylating H3K36 compared with wild-type proteins.2 Further structural analysis elucidated the molecular basis for the enhanced activities of these mutants. Here, NSD2 is linked to cancer.